论文部分内容阅读
目的讨论米非司酮应用于绝经过渡期功能性子宫出血的治疗效果,并进行分析与讨论。方法选择我院自2015年4月至2016年6月接收的96例绝经过渡期功能性子宫出血的患者作为此次研究的观察对象,将其均分为观察组与对照组,每组各48例,其中给予观察组患者米非司酮治疗,给予对照组患者炔诺酮治疗,观察并对两组患者的临床效果进行比较。结果观察组患者的治疗总有效率为95.83%,对照组患者为72.92%,观察组患者治疗总有效率明显优于对照组,且观察组患者的不良反应与并发症的发生率低于对照组,观察组不良反应发生率为4.17%,对照组为8.34%。两者差异具有统计学意义(P<0.05)。结论应用米非司酮对绝经过渡期功能性子宫的治疗具有积极的作用,临床应用价值高,值得推广应用。
Objective To discuss the therapeutic effect of mifepristone applied to functional uterine bleeding in menopause transitional period, and analyze and discuss it. Methods A total of 96 patients with functional dysfunctional uterine bleeding during the period from April 2015 to June 2016 in our hospital were selected as observation subjects and equally divided into observation group and control group with 48 For example, patients in the observation group were treated with mifepristone, and patients in the control group were treated with norethindrone. The clinical effects of the two groups were compared and observed. Results The total effective rate was 95.83% in the observation group and 72.92% in the control group. The total effective rate in the observation group was significantly better than that in the control group, and the incidence of adverse reactions and complications in the observation group was lower than that in the control group The incidence of adverse reactions in the observation group was 4.17% and in the control group was 8.34%. The difference between the two groups was statistically significant (P <0.05). Conclusion The application of mifepristone has a positive effect on the treatment of functional uterus in menopause transitional period, which has high clinical value and is worth popularizing and applying.